04/23/2021 | Press release | Distributed by Public on 04/23/2021 09:15
New Phase 3 Data Showed First-in-Class TREMFYA® (guselkumab) Provided Durable Complete Skin Clearance Through Five Years in Moderate to Severe Plaque Psoriasis (PsO) and Robust[...]
